GLP-1, sarcopenia, and the movement plan elderly patients can't skip

GLP-1 receptor agonists — Ozempic, Wegovy, Mounjaro, Zepbound — are doing something remarkable for patients struggling with metabolic disease. Sustained weight loss of 15–22% of body weight. Better glycemic control. Reduced inflammation. For many of my older patients, these drugs are the first time in a decade the scale has moved.

But there's a conversation most prescribing offices skip, and it's the one that matters most for the patients I see in physical therapy.

A meaningful portion of what you lose on a GLP-1 isn't fat. It's muscle.

What the trials actually show

Across the major GLP-1 weight-loss trials — Wilding et al.'s STEP program with semaglutide and Jastreboff et al.'s SURMOUNT program with tirzepatide — body composition analyses consistently report that 25% to 40% of the total weight lost on these medications comes from lean body mass. Not fat. Muscle, bone-supporting tissue, and water held in muscle.

For a 40-year-old, that's a recoverable hit. The body still builds muscle quickly when given the right stimulus, and the metabolic upside of the drug often outweighs the lean-mass cost.

For a 70-year-old, the math is different.

Sarcopenia is already in motion after 50

The body loses approximately 1% of skeletal muscle mass per year starting around age 50, and that rate accelerates after 70 — sometimes to 2% per year or more if the person is sedentary. This is sarcopenia, and it's the biological driver behind falls, fractures, the loss of independence, and a substantial fraction of geriatric hospitalizations.

When an elderly patient layers GLP-1-induced lean loss on top of an already-thinning muscle baseline, the result isn't just "they got smaller." It's that the same person who weighed less now also has less of the tissue that keeps them upright.

In my 2016 paper in Practical Pain Management, Health and Economic Benefits of Exercise for Seniors, I made the case that regular strength and conditioning for adults 50+ wasn't a lifestyle nicety — it was load-bearing infrastructure for healthspan. The economic data was striking even then: every dollar spent on senior exercise programming pays back multiples in avoided fractures, avoided hospitalizations, and preserved independence.

That argument has not aged. It has intensified in the GLP-1 era.

The movement plan I prescribe alongside GLP-1

For my patients who are on a GLP-1 and over 60, I structure the movement plan around three non-negotiables.

1. Resistance training, twice a week, every week. Two days. Not "when I feel up to it." Bodyweight, bands, or light dumbbells are fine to start — what matters is that the major muscle groups (legs, back, chest, core) see load. The research is consistent: resistance training during caloric deficit dramatically reduces how much of the weight loss comes from muscle. We don't have to choose between fat loss and muscle preservation; we choose them together.

2. Protein floor: 1.2–1.6 grams per kilogram of body weight, per day. Most of my older GLP-1 patients are eating dramatically less because the medication is doing its job — appetite is suppressed. That's fine for fat loss, but it means every meal has to do more work. Protein needs are higher than baseline, not lower. If you weigh 160 lbs (73 kg), that's roughly 90–115 grams of protein a day, distributed across meals.

3. Daily walking, 20+ minutes. Cardiovascular load that doesn't tax the joints, helps preserve glucose-handling capacity, and crucially — keeps the proprioceptive systems that prevent falls in active service. Resistance training builds the engine; daily walking keeps the wiring intact.

I outlined the practical mechanics of this — at-home strength, resistance, and core stability work — in my HealthCentral consumer guide, which most patients can implement without a gym membership or a trainer. That's the version of "exercise" we should be defaulting to for the 50+ population on GLP-1.

What I want every elderly patient on a GLP-1 to hear

The drug is doing its job. The pounds are coming off. That's real, and it's good.

But the body composition reading on your bathroom scale does not tell you whether the loss is fat or function. Six months from now, the question isn't going to be "did you lose weight?" It's going to be "can you still get up off the floor without help?"

If your prescriber didn't talk to you about a movement plan when they started the GLP-1, that's the conversation we should be having in PT before we lose more time.